IBRUTINIB INCREASES THE SYSTEMIC EXPOSURE OF RITUXIMAB: PHARMACOKINETIC RESULTS FROM THE HELIOS TRIAL. (June 2017) - Cramer, P.; Demirkan, F.; Fraser, G.; Pristupa, A.; Bartlett, N.; Dilhuydy, M.; Loscertales, J.; Avigdor, A.; Rule, S.; Samoilova, O.; Goy, A.; Ganguly, S.; et al.